Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 29 pseudogene (RNU7-29P, also known as U7.29 or LOC124904769) is a human genomic locus annotated as a pseudogene related to the U7 small nuclear RNA gene family[4][7][8][9]. Pseudogenes such as RNU7-29P arise from duplication or retrotransposition events but generally do not produce functional RNA or proteins; they lack normal biological activity and are usually not involved in cellular processes or disease mechanisms[7][8]. The functional counterpart, U7 small nuclear RNA, is a component of the U7 snRNP complex essential for histone pre-mRNA processing, but RNU7-29P itself is not implicated in this or any other biological function[6][7]. There is no evidence that RNU7-29P is considered a drug target or biomarker. It is simply annotated as a pseudogene in the human genome and does not currently have any therapeutic relevance or established disease associations[7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 29 pseudogene (RNU7-29P).